US Patent 11236052 Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase
Patent 11236052 was granted and assigned to Translational Drug Development (Td2) on February, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11236052 Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.